Yesterday, NRx Pharmaceuticals soared 61.06% and traded at $10.92. This week, the company made a big leap. The stock on October 7 was $8.25. On October 11, it fell to $6.58. The next day, the price rose to $9.72. NRX Pharmaceuticals (NBSP), announced yesterday that a research New drug module for the production of ZYESAMI ™ has been submitted to the US Food and Drug Administration (FDA). This document confirms that Nephron Pharmaceuticals is ready to supply ZYESAMI on a commercial scale.
Finance and Business reporter
After graduating high school. Lora decided to travel and blog as a part-timer. Today she enjoys what she loves and works remotely as our finance and business reporter